Novo Nordisk to purchase Cardior Prescription drugs for as much as $1.1 billion
COPENHAGEN: Denmark's Novo Nordisk on Monday stated it has agreed to purchase Cardior Prescription drugs for as much as 1.03 billion euros ($1.11 billion) to strengthen its cardiovascular pipeline. The…
0 Comments
March 25, 2024